Applications of accelerator mass spectrometry for pharmacological and toxicological research
- 29 July 2005
- journal article
- review article
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 25 (1) , 127-145
- https://doi.org/10.1002/mas.20059
Abstract
The technique of accelerator mass spectrometry (AMS), known for radiocarbon dating of archeological specimens, has revolutionized high‐sensitivity isotope detection in pharmacology and toxicology by allowing the direct determination of the amount of isotope in a sample rather than measuring its decay. It can quantify many isotopes, including 26Al, 14C, 41Ca, and 3H with detection down to attomole (10−18) amounts. Pharmacokinetic data in humans have been achieved with ultra‐low levels of radiolabel. One of the most exciting biomedical applications of AMS with 14C‐labeled potential carcinogens is the detection of modified proteins or DNA in tissues. The relationship between low‐level exposure and covalent binding of genotoxic chemicals has been compared in rodents and humans. Such compounds include heterocyclic amines, benzene, and tamoxifen. Other applications range from measuring the absorption of 26Al to monitoring 41Ca turnover in bone. In epoxy‐embedded tissue sections, high‐resolution imaging of 14C label in cells is possible. The uses of AMS are becoming more widespread with the availability of instrumentation dedicated to the analysis of biomedical samples.Keywords
This publication has 89 references indexed in Scilit:
- EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGEDrug Metabolism and Disposition, 2004
- Comparison of the mutagenic activity of the benzene metabolites, hydroquinone and para-benzoquinone in the supF forward mutation assay: a role for minor DNA adducts formed from hydroquinone in benzene mutagenicityMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Role of Noninvasive Tests (13C‐Urea Breath Test and Stool Antigen Test) as Additional Tools in Diagnosis of Helicobacter Pylori Infection in Patients with Atrophic Body GastritisHelicobacter, 2004
- Current perspectives of 14 C-isotope measurement in biomedical accelerator mass spectrometryAnalytical and Bioanalytical Chemistry, 2004
- A High-Throughput Method for the Conversion of CO2 Obtained from Biochemical Samples to Graphite in Septa-Sealed Vials for Quantification of 14C via Accelerator Mass SpectrometryAnalytical Chemistry, 2003
- Big physics, small doses: the use of AMS and PET in human microdosing of development drugsNature Reviews Drug Discovery, 2003
- Mass Spectrometric Immunoassay for Parathyroid Hormone-Related ProteinAnalytical Chemistry, 2002
- Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the techniqueXenobiotica, 2001
- Species and Strain Comparisons in the Macromolecular Binding of Extremely Low Doses of [14C]Benzene in Rodents, Using Accelerator Mass SpectrometryToxicology and Applied Pharmacology, 1999
- Assessing human risk to heterocyclic aminesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997